Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells - PubMed (original) (raw)
. 2007 Nov 16;318(5853):1141-3.
doi: 10.1126/science.1148536.
David E Anderson, Lisa Bregoli, William D Hastings, Nasim Kassam, Charles Lei, Rucha Chandwaskar, Jozsef Karman, Ee W Su, Mitsuomi Hirashima, Jeffrey N Bruce, Lawrence P Kane, Vijay K Kuchroo, David A Hafler
Affiliations
- PMID: 18006747
- DOI: 10.1126/science.1148536
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells
Ana C Anderson et al. Science. 2007.
Abstract
CD4+ T helper 1 (TH1) cells are important mediators of inflammation and are regulated by numerous pathways, including the negative immune receptor Tim-3. We found that Tim-3 is constitutively expressed on cells of the innate immune system in both mice and humans, and that it can synergize with Toll-like receptors. Moreover, an antibody agonist of Tim-3 acted as an adjuvant during induced immune responses, and Tim-3 ligation induced distinct signaling events in T cells and dendritic cells; the latter finding could explain the apparent divergent functions of Tim-3 in these cell types. Thus, by virtue of differential expression on innate versus adaptive immune cells, Tim-3 can either promote or terminate TH1 immunity and may be able to influence a range of inflammatory conditions.
Similar articles
- Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells.
Dardalhon V, Anderson AC, Karman J, Apetoh L, Chandwaskar R, Lee DH, Cornejo M, Nishi N, Yamauchi A, Quintana FJ, Sobel RA, Hirashima M, Kuchroo VK. Dardalhon V, et al. J Immunol. 2010 Aug 1;185(3):1383-92. doi: 10.4049/jimmunol.0903275. Epub 2010 Jun 23. J Immunol. 2010. PMID: 20574007 Free PMC article. - TIM-3 in autoimmunity.
Anderson AC, Anderson DE. Anderson AC, et al. Curr Opin Immunol. 2006 Dec;18(6):665-9. doi: 10.1016/j.coi.2006.09.009. Epub 2006 Oct 2. Curr Opin Immunol. 2006. PMID: 17011764 Review. - Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.
Liu Y, Ji H, Zhang Y, Shen X, Gao F, He X, Li GA, Busuttil RW, Kuchroo VK, Kupiec-Weglinski JW. Liu Y, et al. J Hepatol. 2015 Mar;62(3):563-72. doi: 10.1016/j.jhep.2014.10.034. Epub 2014 Oct 31. J Hepatol. 2015. PMID: 25450716 Free PMC article. - Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity.
Frisancho-Kiss S, Nyland JF, Davis SE, Barrett MA, Gatewood SJ, Njoku DB, Cihakova D, Silbergeld EK, Rose NR, Fairweather D. Frisancho-Kiss S, et al. J Immunol. 2006 Jun 1;176(11):6411-5. doi: 10.4049/jimmunol.176.11.6411. J Immunol. 2006. PMID: 16709797 - The TIM gene family regulates autoimmune and allergic diseases.
Meyers JH, Sabatos CA, Chakravarti S, Kuchroo VK. Meyers JH, et al. Trends Mol Med. 2005 Aug;11(8):362-9. doi: 10.1016/j.molmed.2005.06.008. Trends Mol Med. 2005. PMID: 16002337 Review.
Cited by
- Oral N-acetylcysteine ameliorates liver fibrosis and enhances regenerative responses in Mdr2 knockout mice.
Har-Zahav A, Tobar A, Fried S, Sivan R, Wilkins BJ, Russo P, Shamir R, Wells RG, Gurevich M, Waisbourd-Zinman O. Har-Zahav A, et al. Sci Rep. 2024 Nov 3;14(1):26513. doi: 10.1038/s41598-024-78387-2. Sci Rep. 2024. PMID: 39489865 Free PMC article. - T-Cell Immunoglobulin and Mucin Domain 3 (TIM-3) Gene Expression as a Negative Biomarker of B-Cell Acute Lymphoblastic Leukemia.
Basingab FS, Bashanfer M, Alrofaidi AA, Barefah AS, Hammad R, Alahdal HM, Alrahimi JS, Zaher KA, Hassan S, Algiraigri AH, El-Daly MM, Alkarim SA, Aldahlawi AM. Basingab FS, et al. Int J Mol Sci. 2024 Oct 17;25(20):11148. doi: 10.3390/ijms252011148. Int J Mol Sci. 2024. PMID: 39456930 Free PMC article. - The Putative Role of TIM-3 Variants in Polyendocrine Autoimmunity: Insights from a WES Investigation.
Ariolli A, Agolini E, Mazza T, Petrizzelli F, Petrini S, D'Oria V, Cudini A, Nardella C, Pesce V, Comparcola D, Cappa M, Fierabracci A. Ariolli A, et al. Int J Mol Sci. 2024 Oct 12;25(20):10994. doi: 10.3390/ijms252010994. Int J Mol Sci. 2024. PMID: 39456777 Free PMC article. - Galectin-9 - ligand axis: an emerging therapeutic target for multiple myeloma.
Shil RK, Mohammed NBB, Dimitroff CJ. Shil RK, et al. Front Immunol. 2024 Sep 25;15:1469794. doi: 10.3389/fimmu.2024.1469794. eCollection 2024. Front Immunol. 2024. PMID: 39386209 Free PMC article. Review. - Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape.
Inocencio JF, Mitrasinovic S, Asad M, Parney IF, Zang X, Himes BT. Inocencio JF, et al. Front Immunol. 2024 Sep 13;15:1424396. doi: 10.3389/fimmu.2024.1424396. eCollection 2024. Front Immunol. 2024. PMID: 39346924 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- R56 AI067544-02/AI/NIAID NIH HHS/United States
- R01 AI067544-01A2/AI/NIAID NIH HHS/United States
- R01 AI067544/AI/NIAID NIH HHS/United States
- R56 AI067544/AI/NIAID NIH HHS/United States
- R56 AI067544-01A1/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials